Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bukowski

Showing results (71-80 of 357) with videos related to

Pageof 36
Sort By:
Blood|September 1, 1977
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpuraR M Bukowski, J W King, J S Hewlett
European Journal of Cancer & Clinical Oncology|June 1, 1983
Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group StudyR M Bukowski, L P Leichman, S E Rivkin
Expert Review of Anticancer Therapy|November 18, 2010
Burden of metastatic bone disease from genitourinary malignanciesPeter F Mulders, Per-Anders Abrahamsson, Ronald M Bukowski
Cancer|August 15, 1985
Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinomaR E Petras, W R Hart, R M Bukowski
Cancer Treatment Reports|January 1, 1980
Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group StudyR M Bukowski, A LoBuglio, J McCracken, et al.
Current Oncology Reports|April 29, 2010
RANK ligand: effects of inhibitionSaby George, Andrew Brenner, John Sarantopoulos, et al.
Expert Review of Anticancer Therapy|December 23, 2003
Evolving role of pegylated interferons in metastatic renal cell carcinomaToni K Choueiri, Thomas E Hutson, Ronald M Bukowski
Somatic Cell Genetics|January 1, 1980
Isolation of multiple classes of mutants of CHO cells resistant to cyclic AMPM M Gottesman, A LeCam, M Bukowski, et al.
Psychoneuroendocrinology|July 29, 2021
Indirect effects of HPA axis dysregulation in the association between peer victimization and depressed affect during early adolescenceRyan E Adams, Jonathan Bruce Santo, William M Bukowski
The American Journal of Gastroenterology|October 1, 1991
Acute colonic pseudo-obstruction associated with interleukin-2 therapyA B Post, G W Falk, R M Bukowski
Pageof 36

Showing results (71-80 of 357) with videos related to

Sort By:
Pageof 36
Blood|September 1, 1977
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpuraR M Bukowski, J W King, J S Hewlett
European Journal of Cancer & Clinical Oncology|June 1, 1983
Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group StudyR M Bukowski, L P Leichman, S E Rivkin
Expert Review of Anticancer Therapy|November 18, 2010
Burden of metastatic bone disease from genitourinary malignanciesPeter F Mulders, Per-Anders Abrahamsson, Ronald M Bukowski
Cancer|August 15, 1985
Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinomaR E Petras, W R Hart, R M Bukowski
Cancer Treatment Reports|January 1, 1980
Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group StudyR M Bukowski, A LoBuglio, J McCracken, et al.
Current Oncology Reports|April 29, 2010
RANK ligand: effects of inhibitionSaby George, Andrew Brenner, John Sarantopoulos, et al.
Expert Review of Anticancer Therapy|December 23, 2003
Evolving role of pegylated interferons in metastatic renal cell carcinomaToni K Choueiri, Thomas E Hutson, Ronald M Bukowski
Somatic Cell Genetics|January 1, 1980
Isolation of multiple classes of mutants of CHO cells resistant to cyclic AMPM M Gottesman, A LeCam, M Bukowski, et al.
Psychoneuroendocrinology|July 29, 2021
Indirect effects of HPA axis dysregulation in the association between peer victimization and depressed affect during early adolescenceRyan E Adams, Jonathan Bruce Santo, William M Bukowski
The American Journal of Gastroenterology|October 1, 1991
Acute colonic pseudo-obstruction associated with interleukin-2 therapyA B Post, G W Falk, R M Bukowski
Pageof 36